A5: Infection Preventionists (IPs) promote a culture of safety & impact the health of patients, workers, staff, & community members. IPs educate about #antibiotic prescription and the dangers of #AntimicrobialResistance . Learn more: bit.ly/3G07IEP
#ABXRxEquity #USAAW23
A4: Infection Preventionists play a pivotal role in healthcare safety, focusing on #measures that prevent #HealthcareAssociatedInfections #HCAIs and ensuring proper antibiotic use to fighting #AMR . APIC SHEA SIDP CDC Antimicrobial Resistance
#AntimicrobialResistance . #ABXRxEquity #USAAW23
A6: Read the systematic scoping review on health equity and antibiotic prescribing in the U.S. to understand current research and what clinicians, stewardship experts, and health systems can do to advance #ABXRxEquity . bit.ly/47d99eA #BeAntibioticsAware
A3: Use the ABC's of prescribing #antibiotics to patients as a guide. This easy to read and download infographic is a great way to #BeAntibioticsAware and share information with your facilities: bit.ly/3QYAQ5H
#ABXRxEquity #USAAW23 #AntimicrobialResistance
SIDP CDC Antimicrobial Resistance SHEA ACCP INFD PRN A6. Appreciate this framework to promote health equity & include social determinants of health along with ABX access when systematically evaluating ABX use 😬 #USAAW23 #ABXRxEquity gh.bmj.com/content/bmjgh/…
SIDP SHEA ACCP INFD PRN A5: While differences in antibiotic prescribing have been documented at the patient & clinician levels, research is needed on the modifiable drivers of health inequities in the diagnosis & treatment of infections at the national, community, & healthcare levels. #ABXRxEquity
SIDP CDC Antimicrobial Resistance SHEA ACCP INFD PRN Let’s not forget about access to novel antibiotics on the global scale. Check out this joint paper by the CDC Antimicrobial Resistance and World Health Organization (WHO) team in The Lancet
tinyurl.com/mryxcsdt
#USAAW23 #ABXRxEquity
As we wrap up #USAAW23 we want to thank Drs. bethanywattles, E.Mcgee, & Callyn Wren, PharmD for advocating for #ABXRxEquity & sharing their insight into how we can promote health equity to better support optimal antibiotic use for all in our communities! 💜 bit.ly/40TlRgv
SIDP CDC Antimicrobial Resistance SHEA ACCP INFD PRN I think first of access and this work for example we did a while ago now on that topic which made me really reflect on “drug deserts” as an issue for ID pts. #AbxRxEquity
academic.oup.com/jac/article/70…
SIDP SHEA ACCP INFD PRN A6: Read the systematic scoping review on health equity and antibiotic prescribing in the U.S. to understand current research and what clinicians, stewardship experts, and health systems can do to advance #ABXRxEquity . bit.ly/47d99eA #BeAntibioticsAware
SIDP CDC Antimicrobial Resistance SHEA ACCP INFD PRN A6. I like the PROGRESS-plus framework to help consider the many social determinants of health. Can be helpful from a research design and evaluation perspective.
methods.cochrane.org/equity/project… #ABXRxEquity
🥺Didn’t get enough!? 🤭 want more X chat than we did today at #ASPchat and need 🫨 more action??
👀 Check out this upcoming event that is sure to be a great one!! #AbxRxEquity #USAAW23 #BeAntibioticsAware
Oh thank you bethanywattles for letting me know the blog is up and yes love that Peter Simonsson is highlighting #ABXRxEquity
for #USAAW23 #IDTwitter how are y’all including #ABXRxEquity during your week celebration of #USAAW23
Fantastic discussion, references and resources from the #USAAW23 #ABXRxEquity Chat! Check it out! 🙌
SIDP CDC Antimicrobial Resistance SHEA ACCP INFD PRN
Some highlights from our #USAAW23 #ABXRxEquity Chat:
What does #equity in #antibiotic prescribing and access mean to you? #WAAW
From our #USAAW23 #ABXRxEquity Chat:
What do we know about inequities in #antibiotic prescribing? #WAAW
